Corrections or additions?
These articles were prepared for the June 6, 2001 edition of U.S.
1 Newspaper. All rights reserved.
Life in the Fast Lane: InfraStor
It sounds like an entrepreneur’s dream. Put up a
website and just weeks later the federal government comes to your
virtual door and signs a contract worth well over a million dollars.
It happened to David MacRae of InfraStor Technologies Corp. in
"They approached us in March because they saw our website, and they
are back for more, so we must have done a good job," says MacRae. The
federal contract involved storing a Department of Defense website that
contains hundreds of terabytes. (A million megabytes equals one
terabyte). "We pretty much wrote the specifications, and when they put
the contract out for bids, we outbid everyone else."
The name of MacRae’s business is meant to imply "infrastructure,"
because it integrates Storage Area Networks (SAN) and connects large
data storage devices to servers and workstations. "Relatively few
organizations have focused entirely on getting storage area networks
implemented," he says. "It’s not rocket science, but it does require
special knowledge that we have assembled. We have our own integration
laboratory that allows us to model a business situation." He has
relationships with such big suppliers as Gadzoox, Brocade, and
Vixel (fibre channel switch providers), DataCore Software (storage
management software), and ADIC (tape libraries).
"Our clients are medium to large-size organizations looking for
cost-effective ways to manage storage from a central resource. We
take a consultative approach to design a storage solution, customize
it, and provide equipment, software, installation, and training."
Companies with 50 or 100 servers can find it difficult to manage
storage. The question an IT department has to answer: If you have X
number of servers and some of them run out of storage space, do you
buy more storage for each machine or have a centralized source pool
that can allocate gigabytes to each server on demand.
MacRae offers the latter solution: "Putting the storage together into
one common pool uses the capacity 50 percent more effectively, so you
don’t have to buy so much storage." Using open systems modular
hardware, he says, results in an 85 percent reduction in storage
MacRae went to the University of Toronto, Class of 1965, and has a
doctoral degree from there as well. A chemist by training, he was a
researcher for Colgate-Palmolive and Allied Signal (now Honeywell). He
and his wife, who runs a translation business (Specan International)
from their Princeton home, have two grown sons. One
is in a PhD program at UCLA and the other, cellist Alistair MacRae,
went to Princeton University and Manhattan School of Music and made
his debut last month at Carnegie Hall. His additional talent is as
webmaster: He crafted his father’s contract-winning website.
Circle, Montgomery Knoll, Box 8448, Princeton 08543. David M. MacRae,
president. 609-683-8844; fax, 609-683-4906. Home page:
A company that vows to kill pain, Purdue Pharma LP, has
leased 115,000 square feet in Cedar Brook Corporate Center, an office
and science park built by Eastern Properties on Dey Road at Route 130.
The privately held company is known for its research on the principal
cause of human suffering: chronic pain. It does small molecule and
biologics discovery research of the immunological and nervous systems.
"The new facility will be the headquarters of the discovery research
operation," says Merle Spiegel, a spokesperson for the Stamford,
Connecticut, firm. About 100 people will move into the new facility,
and it is expected to open by the end of this year. "Within the next
year or two thereafter, we expect to increase the size of the facility
to 300 people," says Spiegel, noting that Purdue is one of the fastest
growing pharmaceutical firms in the world.
Meanwhile, the contract that Purdue had to manufacture Cytogen
products at 201 College Road ends this month. Purdue Pharma LP paid $4
million for some of Cytogen’s laboratory and manufacturing facilities
early in 1999, and it signed a contract to make Cytogen’s ProstaScint
and OncoScint. Cytogen will now turn to DSM Biologics Company B.V. for
this service, and DSM will make these products at its own site. Purdue
will retain the College Road facility, says Spiegel.
Among Purdue’s products are OxyContin (oxycodone HCl) and MS Contin
(morphine sulfate) for moderate to severe pain, Uniphyl (theophylline,
anhydrous) for asthma, Chirocaine (levobupivacaine injection)
anesthetic, and the over-the-counter Senokot laxatives and Betadine
Purdue is part of an international group of associated companies in 18
countries with more than 4,000 employees. It sponsors Partners Against
Pain, which offers more than 6,000 programs annually to encourage
therapeutic alliances between patients, their families, caregivers,
and healthcare professionals.
- Purdue Pharma LP, Tage Honore, vice president of
discovery research. Cedar Brook Corporate Center. 203-588-8000.
Home page: www.purduepharma.com
- Cytogen Corporation (CYTO), 600 College Road East,
CN 5308, Princeton 08543-5308. H. Joseph Reiser, CEO.
609-987-8200; fax, 609-750-8124. Home page: www.cytogen.com
A Duke University study released on June 5 found that Cytogen’s
prostate cancer screening method, using ProstaScint, identifies the
spread of the cancer "earlier and in more patients than with
previously available imaging methods." ProstaScint is a monoclonal
antibody-based imaging agent that can image the extent and spread of
Prostate cancer is the second leading cause of cancer death among
American men, and more than one in six men develop this cancer.
Chances of survival increase when it is detected early.
Among Cytogen’s other products for prostate and other types of cancer
are BrachySeed, Quadramet, and OncoScint. Cytogen has a pipeline of
oncology products, licensed from Memorial Sloan-Kettering Center, that
use prostate-specific membrane antigen (PSMA) technologies. It has a
subsidiary, AxCell Biosciences, that is charting protein-signaling
pathways for use in drug discovery and development.
- Palatin Technologies Inc. (PTN), 103 Carnegie
Center, Suite 200, Princeton 08540. Carl Spana, CEO. 609-520-1911;
fax, 609-452-0880. Home page: www.palatin.com
Palatin Technologies has signed a lease for 28,000
square feet, the entire building at 4C Cedar Brook Drive. The R&D firm
offers products for sexual dysfunction, appendicitis detection, and
ultrasound testing. It will consolidate
its Carnegie Center and its 15,000 square foot laboratory on May
Street in Edison.
Doug Petrozzini and Ray Sohmer of Grubb & Ellis worked with Stephen
Wills, the CFO of Palatin. The developer, Eastern Properties,
constructed this brand-new building at Cedar Brook Corporate Center.
- Orchid BioSciences Inc. (ORCH), 303A College Road
East, Princeton 08543. Dale R. Pfost Ph.D, CEO. 609-750-2200; fax,
609-750-2250. Home page: www.orchid.com
A Korea-based firm, DNA Link, will be the first Asian company to buy
Orchid’s SNPstream 25K system for high throughput genotyping. DNA Link
will use the system for industrial scale single nucleotide
polymorphism (SNP) scoring — analyzing up to 25,000 SNPs per day —
and will also use Orchid’s SNP databases.
Orchid offers production services and technologies of single
nucleotide polymorphism (SNP) scoring and genetic diversity analysis.
- RCN Corporation (RCNC), 105 Carnegie Center, Suite
300, Princeton 08540. David C. McCourt, chairman and CEO.
609-734-3700; fax, 609-734-7551. Home page: www.rcn.com
The beleaguered cable company, which has laid off
workers and axed plans to build a prestigious campus on the former
Union Camp site, made another cutback on May 24. It announced it would
not make its promised upgrades in Princeton Township and Borough,
among other locations. The Princetons were among the first areas to
get cable installed in the 1970s and they are still using a two-line
coaxial system. Last year RCN had promised to replace those lines with
fiber-optic cable. But in
areas of Hillsborough and Franklin, where upgrades were already well
underway, cabling will be finished by 2003. RCN’s franchise is up for
renewal at the end of next year.
In an effort to recoup some of its losses, Red Basin LLC (one of RCN’s
largest investors) will buy 7.66 million shares of common stock in a
private placement at $6.53 per share. The stock peaked at nearly $75
last year but tumbled along with other telecommunications stocks.
RCN is a national single-source facilities-based communications firm
with services — Internet service, local and long distance phone, and
cable television — to the residential market.
- Maximus, 50 Millstone Road, Building 300, Suite
200, Windsor Corporate Plaza, East Windsor 08520. Marion Reitz,
vice president. 609-919-2800; fax, 609-918-1524.
Maximus has moved from 15,000 square feet at Ibis Plaza on
Quakerbridge Road to 38,000 square feet, occupying the second floor
at Windsor Corporate Park, and has a new phone and fax. The health
education and enrollment HMO has 4,000 employees nationally, and about
160 people work at this location. It is based in Virginia.
- National Alliance for Autism Research, 99 Wall
Street, Princeton 08540. Glenn R. Tringali, chief operations
officer. 609-430-9160; fax, 609-430-9163. Home page:
The alliance expanded in April from 1,000 feet at 414 Wall Street to
3,200 feet at 99 Wall Street and installed Glenn Tringali in May as
chief operations officer. It has eight employees at this location.
Founded in 1984 by Karen Margulis London, the alliance funds and
promotes biomedical research into autism and related developmental
disorders. Tringali is a graduate of Rutgers, Class of 1973, and has
worked for the March of Dimes and several hospital foundations and was
most recently the national director of fundraising for the Juvenile
Diabetes Foundation. "I’m here to manage the growth and anticipated
growth of the foundation, and we are establishing chapters around the
country," says Tringali.
- Icon Genetics Inc., 1 Deer Park Drive, Princeton
Research Center, Suite C, Monmouth Junction 08852. Newell Bascomb,
president. 732-329-1600; fax, 732-329-1616. Home page:
Research on wheat and rapeseed will be funded by a fifth grant from an
agency of the German government, the Federal Ministry of Education and
Research in Berlin. Icon will use the grant’s $2.9 million to decrease
development time for these European crops by using gene recombinations
and plant hybridization techniques.
- WorldWater Corp. (WWAT), 55 Route 31 South,
Pennington Business Park, Pennington 08534. Quentin T. Kelly, CEO.
609-818-0700; fax, 609-818-0720. Www.worldwater.com
CEO Quentin T. Kelly will make a presentation at a conference at the
World Trade Center on Monday, June 11. The New York
Society of Security Analysts is sponsoring the Alternative Energy
Industry Conference, and Kelly will tell about the water and solar
engineering company that
makes solar pumps and solar electrical systems.
Worldwater is working with Rutgers to develop drip-irrigation systems
with its proprietary solar pumping equipment. It is a principal
supplier of renewable energy and remote water supply for emerging
nations — water management and solar energy company, designing,
developing and marketing proprietary technology.
Corrections or additions?
This page is published by PrincetonInfo.com
— the web site for U.S. 1 Newspaper in Princeton, New Jersey.